A possible role for CCR5 in the progression of atherosclerosis in HIV-infected patients: a cross-sectional study

BACKGROUND: Chemokines can block viral entry by interfering with HIV co-receptors and are recognised mediators of atherosclerosis development. A number of experimental drugs that inhibit HIV entry arrest the development of atherosclerosis in animal models. We hypothesised that the expression of chem...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernández-Sender, Laura, Alonso-Villaverde, Carlos, Rull, Anna, Rodríguez-Gallego, Esther, Riera-Borrull, Marta, Hernández-Aguilera, Anna, Camps, Jordi, Beltrán-Debón, Raúl, Aragonès, Gerard, Menendez, Javier A, Joven, Jorge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3663662/
https://www.ncbi.nlm.nih.gov/pubmed/23659629
http://dx.doi.org/10.1186/1742-6405-10-11

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3663662/
https://www.ncbi.nlm.nih.gov/pubmed/23659629
http://dx.doi.org/10.1186/1742-6405-10-11

Ejemplares similares